ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Events

Coeptis Therapeutics Holdings Inc. (COEP)

NASDAQ

$12.07

$--

(0.00%)

Coeptis Therapeutics Holdings Inc. (COEP) Live Price Chart

Page last updated: 2026-02-13 20:59:00

Key Market Data

Market Cap	$64.43M
Open	$11.63
High	$280.00
Low	$2.31
Previous Close	$11.82
Price Change	--
Percentage Change	0.00%
Volume	33K

Coeptis Therapeutics Holdings Inc. (COEP) Stock Price Today

Coeptis Therapeutics Holdings Inc. (COEP) is currently trading at $12.07 as of 2026-02-13 20:59:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned -1,160.44% over the past four weeks. Over the last 12 months, Coeptis Therapeutics Holdings Inc. has recorded a -2.18% price change, indicating a weak performance relative to the broader market.

Coeptis Therapeutics Holdings Inc. (COEP) 7-Day Stock Price Changes

Over the past seven days, Coeptis Therapeutics Holdings Inc. has traded within a short-term range shaped by market sentiment in the FINANCE SERVICES sector. During this period, the stock moved from its previous closing price of $12.22 to the latest recorded price of $12.07, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (33,034), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, COEP has delivered a -1,160.44% return over the past month and a -2.18% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Coeptis Therapeutics Holdings Inc. (COEP)

You can buy and trade COEP on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for COEP and Execute Your Trade

Open the trading page, enter COEP in the search bar, select the amount of COEP you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Coeptis Therapeutics Holdings Inc. (COEP)?

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Coeptis Therapeutics Holdings Inc. Information

Industry	FINANCE SERVICES
Employees	7
Sector	FINANCE SERVICES
Company Website	https://www.coeptistx.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Coeptis Therapeutics Holdings Inc.?

The latest trading price for Coeptis Therapeutics Holdings Inc. (Common Stock) is $ 12.07, compared with a previous closing price of $ 11.82. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for COEP can be tracked on the live chart and quote section on this page.

2.Is Coeptis Therapeutics Holdings Inc. stock going up or down?

Looking at recent performances, COEP has returned -1,160.44% over the past month, -17.67% over the last six months and -2.18% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Coeptis Therapeutics Holdings Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does COEP currently sit relative to its 52-week high and low?

In the most recent 52-week period, Coeptis Therapeutics Holdings Inc. has traded between a low of $ 6.26 and a high of $ 21.41. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether COEP is currently nearer the top or the bottom of its one-year trading band.

4.How is Coeptis Therapeutics Holdings Inc. classified by sector and industry?

Coeptis Therapeutics Holdings Inc. is classified in the FINANCE SERVICES sector. In practice, this means Coeptis Therapeutics Holdings Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing COEP’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the FINANCE SERVICES sector could influence Coeptis Therapeutics Holdings Inc.’s performance.

5.Where is Coeptis Therapeutics Holdings Inc. listed and how large is it by market value?

Coeptis Therapeutics Holdings Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalisation of $ 64.43M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Coeptis Therapeutics Holdings Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does COEP's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -2.37 summarises how much profit Coeptis Therapeutics Holdings Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Coeptis Therapeutics Holdings Inc.'s financial performance over time?

To follow Coeptis Therapeutics Holdings Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how COEP is performing and how the market is responding.

8.When is Coeptis Therapeutics Holdings Inc. expected to report earnings?

Coeptis Therapeutics Holdings Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for COEP, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Coeptis Therapeutics Holdings Inc.'s earnings reports?

Coeptis Therapeutics Holdings Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether COEP is meeting, beating or missing expectations.

10.How can I stay informed about Coeptis Therapeutics Holdings Inc.'s results and guidance?

You can stay up to date on Coeptis Therapeutics Holdings Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for COEP on this page helps you see how new information is being reflected in the stock.

11.Does Coeptis Therapeutics Holdings Inc. pay a regular cash dividend to its shareholders?

Coeptis Therapeutics Holdings Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor COEP's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for COEP?

Based on the latest earnings data, COEP has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Coeptis Therapeutics Holdings Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Coeptis Therapeutics Holdings Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Coeptis Therapeutics Holdings Inc.?

Coeptis Therapeutics Holdings Inc. is a publicly traded company in the FINANCE SERVICES industry within the FINANCE SERVICES sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is COEP valued in terms of P/E ratio and EPS?

Coeptis Therapeutics Holdings Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -2.37. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Coeptis Therapeutics Holdings Inc.'s earnings. Comparing COEP's P/E and EPS to those of other FINANCE SERVICES companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Coeptis Therapeutics Holdings Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalisation

Most Actively Traded

Discover today's most actively traded US stocks

Dick's Sporting Goods, Inc.

DKS

Greif, Inc.

GEF.B

Hecla Mining Company

HomeTrust Bancshares, Inc.

HTB

Klarna Group plc

KLAR

Top Gainers

Browse today's leading gainers in the US stock market

Founder Group Limited

FGL

JIADE LIMITED

JDZG

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalisation

BTC

ETH

MYX

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

COEP-to-USD Calculator

Amount

COEP

USD

1 COEP = 12.066 USD